Zenas BioPharma, Inc. (ZBIO) on GreekSoup https://greeksoup.ai/stocks/us/zbio/ Every dated entry in the public record on Zenas BioPharma, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Zenas BioPharma, Inc.: Schedule 13G filed by BlackRock, Inc., 5.0% of the classhttps://greeksoup.ai/stocks/us/zbio/holders/us:ZBIO:schedule-13:2026-10-27:5a281da0adTue, 27 Oct 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc.: short interest 12,538,549 shares at the 15 October 2026 settlement, 18.83 days to coverhttps://greeksoup.ai/stocks/us/zbio/short-interest/us:ZBIO:short-interest:2026-10-15:b33f7d2497Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/zbio/filings/us:ZBIO:filing:2026-10-13:2bfa4d7e7aTue, 13 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc.: short interest 11,941,601 shares at the 30 September 2026 settlement, 15.48 days to coverhttps://greeksoup.ai/stocks/us/zbio/short-interest/us:ZBIO:short-interest:2026-09-30:f552bcf0c9Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc.: short interest 11,871,346 shares at the 15 September 2026 settlement, 22.43 days to coverhttps://greeksoup.ai/stocks/us/zbio/short-interest/us:ZBIO:short-interest:2026-09-15:fdd944fab0Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc. filed S-3ASR: s-3asrhttps://greeksoup.ai/stocks/us/zbio/filings/us:ZBIO:filing:2026-09-11:7f40bffba7Fri, 11 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc. filed S-8: form s-8https://greeksoup.ai/stocks/us/zbio/filings/us:ZBIO:filing:2026-09-11:091b2a6c2cFri, 11 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc.: Schedule 13G/A filed by InnoCare Pharma Inc., 10.4% of the classhttps://greeksoup.ai/stocks/us/zbio/holders/us:ZBIO:schedule-13:2026-09-08:eaf8e674e8Tue, 08 Sep 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc.: Schedule 13G filed by Wellington Management Group LLP, 10.1% of the classhttps://greeksoup.ai/stocks/us/zbio/holders/us:ZBIO:schedule-13:2026-09-08:f481ac686aTue, 08 Sep 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc.: short interest 11,702,288 shares at the 31 August 2026 settlement, 14.18 days to coverhttps://greeksoup.ai/stocks/us/zbio/short-interest/us:ZBIO:short-interest:2026-08-31:22a8ccaa1bMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc.: Form 144, Zebra Aggregator, LP plans to sell 1,000,000 shares worth $31.9 million around 19 August 2026https://greeksoup.ai/stocks/us/zbio/planned-sales/us:ZBIO:planned-sale:2026-08-19:8fa3214697Wed, 19 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc.: Schedule 13D/A filed by Enavate Sciences GP, LLC, 4.9% of the classhttps://greeksoup.ai/stocks/us/zbio/holders/us:ZBIO:schedule-13:2026-08-19:d3f3fda159Wed, 19 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc.: Schedule 13D/A filed by SR One Capital Management, LLC, 7.7% of the classhttps://greeksoup.ai/stocks/us/zbio/holders/us:ZBIO:schedule-13:2026-08-17:8e189db37dMon, 17 Aug 2026 00:00:00 +0000Schedule 13D/13GNot applicable.

Schedule 13D/13G. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc.: short interest 11,658,986 shares at the 14 August 2026 settlement, 21.06 days to coverhttps://greeksoup.ai/stocks/us/zbio/short-interest/us:ZBIO:short-interest:2026-08-14:493d8ed753Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc. Q2 FY2026 results: revenue $1 million, net income -$111 millionhttps://greeksoup.ai/stocks/us/zbio/results/fy2026-q2/us:ZBIO:result:2026-08-13:db01358bb8Thu, 13 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/zbio/filings/us:ZBIO:filing:2026-08-13:528218cefeThu, 13 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc. filed 8-K: results of operations, officer or director changehttps://greeksoup.ai/stocks/us/zbio/filings/us:ZBIO:filing:2026-08-13:c1413669beThu, 13 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Zenas BioPharma, Inc.: short interest 11,753,566 shares at the 31 July 2026 settlement, 13.83 days to coverhttps://greeksoup.ai/stocks/us/zbio/short-interest/us:ZBIO:short-interest:2026-07-31:19364e3bc3Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>